reports
- GlobalData Healthcare Department
Flexion Therapeutics Inc (FLXN) - Financial Analysis Review
Flexion Therapeutics Inc (FLXN) - Financial Analysis Review Summary Flexion Therapeutics Inc (Flexion) is a pharmaceutical company that develops and commercializes pain therapies. The company's products comprise FX006, FX007, and FX005. Its FX005 is a p38 mitogen-activated protein, kinase inhibitor that contains both analgesic and anti-inflammatory properties. It provides FX006, an injectable, intra-articular, sustained release drug to provide long lasting, local analgesia. GlobalData's Flexi...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.